XAIR - Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket | Benzinga
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.
INVO Bioscience posted quarterly loss of 70 cents per share, versus a year-ago loss of $4.19 per share. The company’s quarterly sales surged 314% year-over-year to $974,894.
INVO Bioscience shares climbed 31.1% to $2.11 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Alaunos Therapeutics, Inc. (NASDAQ: TCRT) shares rose 62.9% to $0.1354 in pre-market trading after falling 12% on Monday.
- reAlpha Tech Corp. (NASDAQ: AIRE) shares surged 57.8% to $9.30 in pre-market trading after jumping around 34% on Monday.
- Hanryu Holdings, Inc. (NASDAQ: HRYU) shares rose 40.2% to $1.36 in pre-market trading after falling 3% on Monday.
- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) shares rose 24.3% to $2.66 in pre-market trading after the company announced process to explore strategic alternatives.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 15.3% to $0.3574 in pre-market trading.
- Absci Corporation (NASDAQ: ABSI) rose 14.4% to $1.43 in pre-market trading. Almirall ...